CN Patent

CN109897034A — 一种高纯度晶型a帕布昔利布及其制备方法和药物组合物

Assigned to Nanjing Cavendish Bio Engineering Technology Co Ltd · Expires 2019-06-18 · 7y expired

What this patent protects

本发明公开了一种高纯度晶型A帕布昔利布，所述高纯度晶型A帕布昔利布包含杂质A和/或杂质B都分别小于0.1重量％，帕布昔利布纯度不低于99.5％。此外，还提供了所述高纯度晶型A帕布昔利布的制备方法、药物组合物及用途。

USPTO Abstract

本发明公开了一种高纯度晶型A帕布昔利布，所述高纯度晶型A帕布昔利布包含杂质A和/或杂质B都分别小于0.1重量％，帕布昔利布纯度不低于99.5％。此外，还提供了所述高纯度晶型A帕布昔利布的制备方法、药物组合物及用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN109897034A
Jurisdiction
CN
Classification
—
Expires
2019-06-18
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Cavendish Bio Engineering Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.